A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)
NCT01535118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2765
Last updated 2017-03-03
Summary
This study will gather information on allergic rhinoconjunctivitis from surveys completed by adults and children.
Conditions
- Allergic Rhinoconjunctivitis
Sponsors & Collaborators
-
ALK-Abelló A/S
lead INDUSTRY
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
More Related Trials
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574704 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
NCT01085526 ·Status: COMPLETED ·Phase: NA
-
Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
NCT01777438 ·Status: COMPLETED
-
A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
NCT04878354 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
NCT00978029 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
NCT01454531 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)
NCT00783198 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observational Study of Allergic Rhinitis in Children
NCT05655858 ·Status: COMPLETED
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574223 ·Status: COMPLETED ·Phase: PHASE2
-
Is There a Comorbidity Between Migraine and Allergic Rhinitis?
NCT01845051 ·Status: COMPLETED
-
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
NCT04670627 ·Status: COMPLETED
-
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 ·Status: COMPLETED
-
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
NCT00533208 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis
NCT02488447 ·Status: COMPLETED
-
Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
NCT07315945 ·Status: RECRUITING
-
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
NCT00584051 ·Status: TERMINATED
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
NCT06778213 ·Status: RECRUITING ·Phase: PHASE4
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)
NCT00770315 ·Status: COMPLETED ·Phase: PHASE2/PHASE3